Metabolomic Technologies Inc. is a company developing metabolomics-based in vitro diagnostics for cancer and other diseases. Our lead product is PolypDx™.
Edmonton, Alberta CANADA
Joined November 2013
- Tweets195
- Following335
- Followers256
- Likes182
MTI is hiring! We are hiring a Research Director to join our dynamic Edmonton team. Apply now. bit.ly/3fQlf5M
#metabolomics #diagnostics #colorectalcancer
MTI is hiring! We are seeking a Research Associate to join our exciting Edmonton team. Apply now. Check out our website for details. bit.ly/3fQlf5M
#metabolomics #healthcare #massSpectrometry @PolypDx #yeg #diagnostics #colorectalcancer
Are you a U.S. resident? Today we are excited to launch GetPolypDx.com for orders from U.S. patients. Our test is an easy, urine screening test for detection of precancerous polyps - the precursor to colorectal cancer. #cancerprevention #polypdx #colorectalcancer
Met some great students at the University of Alberta today. #AIMSS2020Symposium – at Edmonton, Alberta
Great symposium, excellent talks. We are enjoying the time with other health tech companies highlighting the possibilities of AI in medicine. – at Edmonton, Alberta
The #AIMSS2020Symposium is in full swing! If you have time today, stop by in the KATZ atrium to say hi, network, and see some great talks. aimss.ca/2020-symposium
It’s great to be at the AI in Healthcare Conference #ualbertaAIMSS today showcasing @PolypDx, our urine screening test for colorectal cancer, powered by AI. #AIMSS2020symposium
Metabolomic Technologies Inc. retweeted
Have you asked yourself, "Do I need to get screened for colorectal cancer?"
Yes! All men and women should be screened for colorectal cancer! The American Cancer Society recently recommended that adults without a family history should begin colorectal cancer screening at age 45.
More convenient for you, a fresh new look for us!
As we move forward in 2020, with exciting plans ahead, we have updated our website, and have a fresh new look. Check us out at mtidx.com.
We are at JP Morgan #JPM2020 in San Francisco all week! Connect with our CEO David Chang @AlphaChalk to find out more about our @PolypDx urine test for colorectal cancer screening.
That was a great day and a great start to a wonderful relationship here in #yeg.
This Post is from an account that no longer exists. Learn more
All set up and excited to be at the #ASTechAwards annual showcase tonight! @ASTechFDN is celebrating their 30th year supporting and highlighting innovation. It’s going to be a great night! @PolypDx
Our flagship product, @PolypDx, offers a convenient and easy way to detect #colorectalcancer at its earliest stage.
#DidYouKnow Colorectal Cancer remains one of the biggest cancer killers in the world. It is the 4th most commonly diagnosed cancer and the 3rd leading cause of cancer death in the US.
Learn how we are changing the approach to colorectal cancer screenings: bit.ly/32uUCtP
The support and investment of our partners @ABInnovates accelerates our product development and supports the delivery of our test to patients.
Congratulations @MetabolomicTech!! We are proud to have supported them in developing the world's first and only urine test for colorectal cancer screening. Well deserved.
We are grateful to @UAlberta_FoMD for creating opportunity through the discovery of this life-saving technology. #CRC #getscreened
Being part of the @ATCyeg provides us with the great startup culture we need to succeed.
Congrats to ATC member @MetabolomicTech on successfully raising $4.2 million dollar Series A funding. #yegtech #HealthTech markets.businessinsider.com/…
Thank you @Yeghealthcity. It’s partners like you that help us be a success!
Congratulations to Edmonton’s own @MetabolomicTech who secured a $4.2M Series A Financing Round! Read more here: ow.ly/t2BH30pKTI0 #heathtech #lifesciences #raisingcapital #yeg #edmonton
Thanks for your support @maelstream. It’s great to be part of an innovation community with companies like yours.
This Post is from an account that no longer exists. Learn more
This is exciting for us as we continue moving forward in our goal: to deliver our easy-to use, innovative test to impact the health of patients worldwide. markets.businessinsider.com/… @PolypDx #getscreened #colorectalcancer
Metabolomic Technologies Inc. retweeted
Congratulations to the @ATCyeg member @MetabolomicTech on being recognized for their exceptional achievements in life sciences. The company was named Company of the Year and earned a Scientific Achievement and Innovation award. 🙌 @PolypDx @Bioalberta businesswire.com/news/home/2…
Our founder, Dr. Richard Fedorak, is being honoured posthumously tonight at the @Bioalberta Awards Gala. We move forward with his legacy - to address colorectal cancer’s greatest unmet need - an easy-to-use, accurate colorectal cancer screening test to save lives. @PolypDx
